Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
2.150
0.00 (0.00%)
Nov 22, 2024, 3:52 PM EST - Market closed
Calidi Biotherapeutics Stock Forecast
CLDI's stock price has decreased by -87.41% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CLDI stock have an average target of 16.67, with a low estimate of 10 and a high estimate of 20. The average target predicts an increase of 675.35% from the current stock price of 2.15.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 27, 2024.
Analyst Ratings
The average analyst rating for CLDI stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +365.12% | Jun 27, 2024 |
| Baird | Baird | Buy Maintains $45 → $20 | Buy | Maintains | $45 → $20 | +830.23% | May 15, 2024 |
| Baird | Baird | Buy Maintains $90 → $45 | Buy | Maintains | $90 → $45 | +1,993.02% | Mar 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $110 → $20 | Strong Buy | Maintains | $110 → $20 | +830.23% | Mar 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $110 | Strong Buy | Initiates | $110 | +5,016.28% | Nov 22, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.05
from -17.30
EPS Next Year
-0.92
from -4.05
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.74 | -0.62 | -0.43 |
| Avg | -4.05 | -0.92 | -0.73 |
| Low | -4.29 | -1.20 | -1.01 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.